Nikolaeva Aleksandra

Ms. Nikolaeva Aleksandra

neurology, radiology, Almazov National Medical Research Center, 2, Akkuratova St., St. Petersburg, 197341, Saint Petersburg, Sankt-Peterburg, Russia
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2023 in Pathophysiology
Verified
Journal Article
Open access
PDF file
Samvel TonyanSamvel Tonyan
Samvel Tonyan
MPMaria Pospelova
Maria Pospelova
Варвара КрасниковаВарвара Красникова
Варвара Красникова
OFOlga Vladimirovna Fionik
Olga Vladimirovna Fionik
TATatyana Alekseeva
Tatyana Alekseeva
Maxim ShevtsovMaxim Shevtsov
Maxim Shevtsov
Damage to the peripheral nervous system (PNS) is a common complication of breast cancer (BC) treatment, with 60 to 80% of breast cancer survivors experiencing symptoms of PNS damage. In the current study, the levels of brain-derived neurotrophic factor (BDNF), galectin-3 (Gal-3), and neurotrophin-3 (NT-3) were measured in the blood serum of BC patients by ELISA as potential biomarkers that might indicate the PNS damage. Sixty-seven patients were enrolled in this multi-center trial and compared to the aged-matched healthy female volunteers (control group) (n = 25). Intergroup comparison of biomarker levels (i.e., Gal-3 and BDNF) did not show significant differences in any of the studied subgroups. However, intriguingly, NT-3 levels were significantly higher in BC patients as compared to healthy volunteers, constituting 14.85 [10.3; 18.0] and 5.74 [4.56; 13.7] pg/mL, respectively (p < 0.001). In conclusion, NT-3 might be employed as a potential biomarker in BC patients with clinical manifestations of PNS damage. However, further studies to validate its correlation to the degree of peripheral nervous system lesions are of high value.

17 October 2022 in Pathophysiology
Verified
Journal Article
Open access
PDF file
Tatyana BukkievaTatyana Bukkieva
Tatyana Bukkieva
MPMaria Pospelova
Maria Pospelova
AEAleksandr Efimtsev
Aleksandr Efimtsev
OFOlga Vladimirovna Fionik
Olga Vladimirovna Fionik
TATatyana Alekseeva
Tatyana Alekseeva
Maxim ShevtsovMaxim Shevtsov
Maxim Shevtsov
Complex breast cancer (BC) treatment can cause various neurological and psychiatric complications, such as postmastectomy pain syndrome, vestibulocerebellar ataxia, and depression, which can lead to microstructural damage of the white matter tracts of the brain. The purpose of the study is to assess microstructural changes in the white matter tracts of the brain in BC survivors using diffusion tensor imaging (DTI). Single DTI scans were performed on patients (n = 84) after complex BC treatment (i.e., surgery, chemotherapy and/or radiation therapy) and on the control group (n = 40). According to the results, a decrease in the quantitative anisotropy (FDR ≤ 0.05) was revealed in the bilateral corticospinal tracts, cerebellar tracts, corpus callosum, fornix, left superior corticostriatal and left corticopontine parietal in patients after BC treatment in comparison to the control group. A decrease in the quantitative anisotropy (FDR ≤ 0.05) was also revealed in the corpus callosum and right cerebellar tracts in patients after BC treatment with the presence of postmastectomy pain syndrome and vestibulocerebellar ataxia. The use of DTI in patients after BC treatment reveals microstructural properties of the white matter tracts in the brain. The results will allow for the improvement of treatment and rehabilitation approaches in patients receiving treatment for breast cancer.

15 June 2023 in Pathophysiology
Verified
Journal Article
Open access
PDF file
Nikolaeva AleksandraNikolaeva Aleksandra
Nikolaeva Aleksandra
MPMaria Pospelova
Maria Pospelova
Варвара КрасниковаВарвара Красникова
Варвара Красникова
AMAlbina Makhanova
Albina Makhanova
Samvel TonyanSamvel Tonyan
Samvel Tonyan
Maxim ShevtsovMaxim Shevtsov
Maxim Shevtsov
Vestibulo-atactic syndrome (VAS), which represents a combination of motor and vestibular disorders, can be manifested as a clinical complication of breast cancer treatment and has a significant impact on patients’ quality of life. The identification of novel potential biomarkers that might help to predict the onset of VAS and its progression could improve the management of this group of patients. In the current study, the levels of intercellular cell adhesion molecule 1 (ICAM-1), platelet/endothelial cell adhesion molecule 1 (PECAM-1), NSE (neuron-specific enolase), and the antibodies recognizing NR-2 subunit of NMDA receptor (NR-2-ab) were measured in the blood serum of BC survivor patients with vestibulo-atactic syndrome (VAS) and associated with the brain connectome data obtained via functional magnetic resonance imaging (fMRI) studies. A total of 21 patients were registered in this open, single-center trial and compared to age-matched healthy female volunteers (control group) (n = 17). BC patients with VAS demonstrated higher serum levels of ICAM-1, PECAM-1, and NSE and a lower value of NR-2-ab, with values of 654.7 ± 184.8, 115.3 ± 37.03, 49.9 ± 103.9, and 0.5 ± 0.3 pg/mL, respectively, as compared to the healthy volunteers, with 230.2 ± 44.8, 62.8 ± 15.6, 15.5 ± 6.4, and 1.4 ± 0.7 pg/mL. According to the fMRI data (employing seed-to-voxel and ROI-to-ROI methods), in BC patients with VAS, significant changes were detected in the functional connectivity in the areas involved in the regulation of postural-tonic reflexes, the coordination of movements, and the regulation of balance. In conclusion, the detected elevated levels of serum biomarkers may reveal damage to the CNS neurons and endothelial cells that is, in turn, associated with the change in the brain connectivity in this group of patients.

12 March 2025 in Pathophysiology
Verified
Journal Article
Open access
PDF file
Nikolaeva AleksandraNikolaeva Aleksandra
Nikolaeva Aleksandra
MPMaria Pospelova
Maria Pospelova
Варвара КрасниковаВарвара Красникова
Варвара Красникова
AMAlbina Makhanova
Albina Makhanova
Samvel TonyanSamvel Tonyan
Samvel Tonyan
Maxim ShevtsovMaxim Shevtsov
Maxim Shevtsov
Chemotherapy-related cognitive impairment termed «chemobrain» is a prevalent complication in breast cancer survivors that requires early detection for the development of novel therapeutic approaches. Magnetic resonance voxel morphometry (MR morphometry), due to its high sensitivity, might be employed for the evaluation of the early changes in the volumes of brain structures in order to explore the «chemobrain» condition. Methods: The open, prospective, single-center study enrolled 86 breast cancer survivors (43.3 ± 4.4 years) and age-matched 28 healthy female volunteers (44.0 ± 5.68). Conventional MR sequences (T1- and T2-weighted, TIRM, DWI, MPRAGE) were obtained in three mutually perpendicular planes to exclude an organ pathology of the brain. Additionally, the MPRAGE sequence was performed for subsequent MR morphometry of the volume of brain structures using the open VolBrain program. The evaluation was performed at two follow-up visits 6 months and 3 years after the completion of BC treatment. Results: According to the MR morphometry, breast cancer survivors presented with significantly decreased volumes of brain structures (including total brain volume, cerebellum volume, subcortical gray matter, etc.) as compared to healthy volunteers. Evaluation over the follow-up period of 3 years did not show the restoration of brain volume structures. Conclusions: The data obtained employing MR morphometry revealed significant reductions (that were not detected on the conventional MR sequences) in both gray and white matter in breast cancer survivors following chemotherapy. This comprehensive analysis indicated the utility of MR morphometry in detecting subtle yet statistically significant neuroanatomical changes associated with cognitive and motor impairments in patients, which can in turn provide valuable insights into the extent of structural brain alterations, helping to identify specific regions that are most affected by treatment.

18 February 2026 in Current Oncology
Verified
Journal Article
Open access
PDF file
MVMark Voynov
Mark Voynov
MPMaria Pospelova
Maria Pospelova
Nikolaeva AleksandraNikolaeva Aleksandra
Nikolaeva Aleksandra
Варвара КрасниковаВарвара Красникова
Варвара Красникова
AMAlbina Makhanova
Albina Makhanova
Maxim ShevtsovMaxim Shevtsov
Maxim Shevtsov
Advances in cancer therapy have markedly improved survival rates; however, long-term neurological sequelae represent a significant clinical challenge. Cancer treatment-related cognitive impairment (CRCI), commonly referred to as “chemobrain”, affects a substantial proportion of cancer survivors and encompasses a broad spectrum of neuropsychiatric and cognitive symptoms, including anxiety, depression, fatigue, balance disturbances, and deficits in attention, memory, processing speed, and executive function. Increasing evidence suggests that these manifestations reflect accelerated biological aging of the brain, rather than merely transient toxic effects. This review synthesizes current clinical, molecular, and neuroimaging evidence supporting the concept of accelerated brain aging associated with multimodal cancer therapy. We summarize key molecular and cellular mechanisms including oxidative stress, neuroinflammation, blood–brain barrier dysfunction, mitochondrial impairment, cellular senescence with a senescence-associated secretory phenotype, and epigenetic remodeling that overlap with physiological brain aging hallmarks. Particular attention is given to circulating molecular biomarkers of accelerated aging, such as inflammatory mediators, senescence markers, endothelial and neuronal injury indicators, and epigenetic age acceleration, and their potential translational relevance. We discuss clinical and neuropsychological data alongside structural and functional magnetic resonance imaging findings demonstrating cortical thinning, altered gyrification, white matter microstructural changes, disrupted functional connectivity, and increased brain age estimates following cancer therapy. Framing CRCI within an accelerated brain aging paradigm may improve risk stratification, guide biomarker development, and inform personalized survivorship care.

19 April 2025 in Bulletin of Rehabilitation Medicine
Verified
Journal Article
Open access
PDF file
Варвара КрасниковаВарвара Красникова
Варвара Красникова
OFOlga V. Fionik
Olga V. Fionik
MPMaria Pospelova
Maria Pospelova
MGMichael Galagudza
Michael Galagudza
AMAlbina M. Makhanova
Albina M. Makhanova
EDElena Demchenko
Elena Demchenko
INTRODUCTION. Postmastectomy upper limb lymphedema is a common complication of radical treatment for breast cancer, leading to a significant reduction in the quality of life. Physical exercises are one of the most important components of rehabilitation for lymphedema. However, there are currently no recommendations for selecting the optimal parameters of physical training, particularly strength training, in this clinical group. One way to assess the safety of using strength loads in patients with postmastectomy upper limb lymphedema may be to analyze the adaptive response of the microcirculatory bed to the exercise regimen. AIM. To analyze the adaptive response of the microcirculatory bed to strength training in patients with postmastectomy upper limb lymphedema. MATERIALS AND METHODS. A cohort comparative interventional study was conducted, which included 36 patients with postmastectomy upper limb lymphedema, divided into the main group (n = 16, stage I–II postmastectomy upper limb lymphedema) and the comparison group (n = 20, stage 0 postmastectomy upper limb lymphedema), as well as 18 healthy female volunteers. Patients in the main and control groups underwent a physical examination and indirect lymphoscintigraphy of the upper limbs. The intervention consisted of a set of strength exercises with free weights (dumbbells) for the muscles of the upper shoulder girdle and upper limbs. To assess the adaptive response of the microcirculatory bed to strength loads in the main group, comparison group, and control group, laser Doppler flowmetry was performed before the exercises, 10 minutes, and 20 minutes after the exercise complex. RESULTS AND DISCUSSION. In the main group, a change in the functioning of the microcirculatory bed was detected: a decrease in nutritive blood flow to 2.52 and signs of stagnation in the venous segment. In the comparison group, a reduction in the neurogenic component of microcirculation to 9.4 was observed, which may indicate a decrease in blood filling at the arteriole level as one of the pathogenetic mechanisms of PMLC progression. In the main group, an improvement in microcirculatory function was noted after performing a set of resistance exercises, manifested by an intensification of nutritive blood flow to 2.89, as well as a reduction in signs of stagnation in the resorptive segment. CONCLUSION. Strength training in patients with postmastectomy upper limb lymphedema leads to an improvement in the functioning of the microcirculatory bed in the early post-exercise period due to the intensification of nutritive blood flow and a reduction in pressure in the resorptive segment of the microcirculatory bed.